BackAssembly Biosciences Overview
Assembly Biosciences Inc

Assembly Biosciences Target Price

See Assembly Biosciences's analyst price targets ($45) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$29.95

Average Target Price

$45.0050.3% upside

1 analysts in the last 4 months

High: $45 | Low: $45

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-15Mizuho Securities$4550.3% upsideOpen
2025-11-20Mizuho SecuritiesSalim Syed$4033.6% upsideOpen
2025-09-24JMP SecuritiesRoy Buchanan$3826.9% upsideOpen
2024-09-24Mizuho SecuritiesSalim Syed$3620.2% upsideOpen
2024-09-20JefferiesDennis Ding$3516.9% upsideOpen

Assembly Biosciences (ASMB) FAQ

The latest target price for ASMB is $45. Investors often review this figure alongside Assembly Biosciences's historical trend and sector peers before judging valuation or financial health.

Assembly Biosciences trades near $29.95 while the consensus target sits at $45 (50.3% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting ASMB's target price ($45), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Assembly Biosciences's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.